Medpace Holdings (MEDP) Financials

$592.42

$1.13 (0.19%)

As on 08-Sep-2026 13:36EDT

Market cap

$16,504 Mln

Revenue (TTM)

$2,782 Mln

P/E Ratio

34.7

P/B Ratio

38.2

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	2,782.29	2,530.23	2,109.05	1,885.84	1,460.00	1,142.38
Cost of Revenue	1,982.07	1,769.62	1,452.75	1,361.34	1,027.56	814.22
Gross Profit	800.22	760.62	656.31	524.51	432.44	328.16
Operating Expenses	216.81	225.68	209.44	187.68	153.74	129.54
Operating Profit (EBIT)	583.40	534.94	446.87	336.83	278.70	198.62
Other Income	--	--	--	--	7.07	3.34
Profit before Tax	598.92	542.38	475.92	335.68	282.86	201.85
Provision for Tax	107.42	91.25	71.54	52.87	37.49	20.00
Profit after Tax (Net Income)	491.50	451.12	404.39	282.81	245.37	181.85
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	245.37	181.85

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	433.86	459.07	825.55	558.95	386.39	952.93
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	187.89	172.65	170.77	172.75	162.64	149.79
Current Liabilities	1,435.43	1,343.75	1,104.55	925.13	803.47	557.22
Total Liabilities	3,492.61	1,975.47	2,100.87	1,656.83	1,352.50	1,659.94

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	1,006.90	985.85	1,071.64	1,063.00	1,018.53	969.02
Current Assets	1,050.29	989.62	1,029.23	593.83	333.96	690.91
Total Assets	3,492.61	1,975.47	2,100.87	1,656.83	1,352.50	1,659.94
Total Debt*	120.10	250.50	149.52	142.12	188.87	130.97
Net Current Assets	-385.14	-354.12	-75.32	-331.30	-469.51	133.70

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	713.22	608.82	433.37	388.05	263.33
Cash Flow from Investing Activities	--	-31.14	-28.31	-34.63	-38.74	-31.36
Cash from Financing Activities	--	-860.39	-154.01	-182.64	-775.78	-44.45
Net Cash Inflow / Outflow	--	--	--	--	-426.47	187.51

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	16.90	15.58	12.63	8.89	7.57	4.82
Cash EPS ($)	--	16.55	13.55	9.68	8.26	5.38
Adjusted Book Value ($)	--	15.85	25.79	17.56	11.92	25.25
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	24.62	19.02	13.62	11.97	6.98
Free Cash Flow per Share ($)	--	23.54	17.88	12.47	10.83	6.23

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	53.56	48.25	44.32	29.58	18.14
ROE (%)	110.09	70.23	58.42	59.83	36.64	20.68
ROA (%)	15.64	22.13	21.52	18.80	16.29	11.92
EBIT Margin (%)	21.13	21.44	22.57	17.83	19.57	17.68
Net Margin (%)	17.67	17.83	19.17	15.00	16.73	15.87
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	24.67	0.20	0.12	0.29	0.28	0.23
EBIT Growth (%)	18.70	13.96	41.57	17.64	41.50	20.90
Net Profit Growth (%)	17.50	11.56	42.99	15.26	34.93	25.08
EPS Growth (%)	26.84	0.23	0.42	0.17	0.57	0.25
Book Value Growth (%)	164.02	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	34.72	36.06	26.30	34.49	28.07	45.17
Price / Book Value	38.18	35.44	12.88	17.45	17.82	8.62
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	26.47	28.08	20.03	26.63	22.87	35.34
Close Price ($)	529.59	561.65	332.23	306.53	212.41	217.64
High Price ($)	628.92	626.26	459.77	317.57	235.72	231.00
Low Price ($)	306.70	250.05	277.72	167.00	126.95	130.74
Market Cap ($ Cr)	16,503.88	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	0.55	0.18	0.25	0.49	0.14
Short term debt to equity ratio	--	0.05	0.03	0.52	0.13	0.17
Current Ratio	0.73	0.74	0.93	0.64	0.42	1.24
Quick Ratio	0.73	--	--	0.64	--	--
Interest Coverage	--	--	19.04	688.87	98.37	1,923.40

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	15.88	15.89	14.06	15.82	17.36	16.32
Asset Turnover	0.89	1.24	1.12	1.25	0.97	0.75
Receivable days	--	50.42	51.51	53.44	55.02	55.54
Inventory Days	--	--	--	--	--	--
Payable days	--	6.26	8.10	8.71	10.44	11.71
Cash Conversion Cycle	--	--	43.41	44.73	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)